Takeda Pharmaceutical Co Ltd (TAK)
13.28
-0.08
(-0.60%)
USD |
NYSE |
May 07, 16:00
13.06
-0.22
(-1.66%)
Pre-Market: 08:38
Takeda Pharmaceutical Total Assets (Quarterly): 100.85B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 100.85B |
| September 30, 2023 | 99.55B |
| June 30, 2023 | 102.16B |
| March 31, 2023 | 104.75B |
| December 31, 2022 | 103.00B |
| September 30, 2022 | 100.98B |
| June 30, 2022 | 102.97B |
| March 31, 2022 | 107.97B |
| December 31, 2021 | 110.35B |
| September 30, 2021 | 112.20B |
| June 30, 2021 | 114.50B |
| March 31, 2021 | 117.05B |
| December 31, 2020 | 119.13B |
| September 30, 2020 | 117.48B |
| June 30, 2020 | 117.23B |
| March 31, 2020 | 118.63B |
| December 31, 2019 | 119.67B |
| September 30, 2019 | 119.31B |
| June 30, 2019 | 125.59B |
| March 31, 2019 | 124.40B |
| December 31, 2018 | 52.26B |
| September 30, 2018 | 37.60B |
| June 30, 2018 | 37.64B |
| March 31, 2018 | 38.64B |
| December 31, 2017 | 39.12B |
| Date | Value |
|---|---|
| September 30, 2017 | 38.90B |
| June 30, 2017 | 38.79B |
| March 31, 2017 | 38.88B |
| December 31, 2016 | 35.61B |
| September 30, 2016 | 37.56B |
| June 30, 2016 | 37.13B |
| March 31, 2016 | 34.02B |
| December 31, 2015 | 34.78B |
| September 30, 2015 | 35.15B |
| June 30, 2015 | 35.21B |
| March 31, 2015 | 35.79B |
| December 31, 2014 | 38.95B |
| September 30, 2014 | 41.79B |
| June 30, 2014 | 43.75B |
| March 31, 2014 | 44.40B |
| December 31, 2013 | 42.18B |
| September 30, 2013 | 43.47B |
| June 30, 2013 | 39.94B |
| March 31, 2013 | 43.04B |
| December 31, 2012 | 44.00B |
| September 30, 2012 | 44.85B |
| June 30, 2012 | 43.70B |
| March 31, 2012 | 43.82B |
| December 31, 2011 | 44.03B |
| September 30, 2011 | 45.60B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
99.55B
Minimum
Sep 2023
125.59B
Maximum
Jun 2019
111.23B
Average
112.20B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Astellas Pharma Inc | 23.89B |
| Nxera Pharma Co Ltd | 1.115B |
| PeptiDream Inc | 492.57M |
| Stemcell Holdings Inc | 12.03M |
| Healios KK | 107.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.04B |
| Shareholders Equity (Quarterly) | 47.81B |
| Debt to Equity Ratio | 0.6918 |
| Current Ratio | 1.064 |
| Net Debt Paydown Yield | -0.13% |